5/1
11:25 am
fold
Will Amicus Therapeutics (FOLD) Report Negative Q1 Earnings? What You Should Know [Yahoo! Finance]
Low
Report
Will Amicus Therapeutics (FOLD) Report Negative Q1 Earnings? What You Should Know [Yahoo! Finance]
5/1
07:00 am
fold
Amicus Therapeutics to Announce First Quarter 2024 Financial Results on May 9, 2024
Medium
Report
Amicus Therapeutics to Announce First Quarter 2024 Financial Results on May 9, 2024
4/19
10:54 am
fold
When Will Amicus Therapeutics, Inc. (NASDAQ:FOLD) Become Profitable? [Yahoo! Finance]
Low
Report
When Will Amicus Therapeutics, Inc. (NASDAQ:FOLD) Become Profitable? [Yahoo! Finance]
3/29
12:57 pm
fold
Why Is Amicus Therapeutics (FOLD) Down 8.1% Since Last Earnings Report? [Yahoo! Finance]
Low
Report
Why Is Amicus Therapeutics (FOLD) Down 8.1% Since Last Earnings Report? [Yahoo! Finance]
3/20
07:12 am
fold
Amicus Therapeutics Issues 2024 Environmental, Social, and Governance (ESG) Report [Yahoo! Finance]
Low
Report
Amicus Therapeutics Issues 2024 Environmental, Social, and Governance (ESG) Report [Yahoo! Finance]
3/20
07:00 am
fold
Amicus Therapeutics Issues 2024 Environmental, Social, and Governance (ESG) Report
Low
Report
Amicus Therapeutics Issues 2024 Environmental, Social, and Governance (ESG) Report
3/18
02:51 pm
fold
Amicus Therapeutics, Inc. (NASDAQ: FOLD) had its price target lowered by analysts at JPMorgan Chase & Co. from $21.00 to $19.00. They now have an "overweight" rating on the stock.
Low
Report
Amicus Therapeutics, Inc. (NASDAQ: FOLD) had its price target lowered by analysts at JPMorgan Chase & Co. from $21.00 to $19.00. They now have an "overweight" rating on the stock.
3/7
12:13 am
fold
Director Margaret Mcglynn Sells 15,000 Shares of Amicus Therapeutics Inc (FOLD) [Yahoo! Finance]
Low
Report
Director Margaret Mcglynn Sells 15,000 Shares of Amicus Therapeutics Inc (FOLD) [Yahoo! Finance]
3/2
09:33 am
fold
Amicus Therapeutics, Inc. (NASDAQ:FOLD) Just Reported Annual Earnings: Have Analysts Changed Their Mind On The Stock? [Yahoo! Finance]
Low
Report
Amicus Therapeutics, Inc. (NASDAQ:FOLD) Just Reported Annual Earnings: Have Analysts Changed Their Mind On The Stock? [Yahoo! Finance]
3/1
07:00 am
fold
Amicus Therapeutics to Present at Upcoming Investor Conferences in March 2024
Medium
Report
Amicus Therapeutics to Present at Upcoming Investor Conferences in March 2024
2/29
02:34 pm
fold
Amicus Therapeutics, Inc. (NASDAQ: FOLD) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $22.00 price target on the stock.
Low
Report
Amicus Therapeutics, Inc. (NASDAQ: FOLD) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $22.00 price target on the stock.
2/29
12:55 pm
fold
Amicus' (FOLD) Q4 Earnings Beat, Revenues Meet Estimates [Yahoo! Finance]
Low
Report
Amicus' (FOLD) Q4 Earnings Beat, Revenues Meet Estimates [Yahoo! Finance]
2/29
11:43 am
fold
Amicus Therapeutics, Inc. (NASDAQ:FOLD) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
Low
Report
Amicus Therapeutics, Inc. (NASDAQ:FOLD) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
2/29
08:14 am
fold
In Sickness. Men and the Culture of Caregiving Launches as Podcast Sharing Powerful Stories of Male Caregivers [Yahoo! Finance]
Medium
Report
In Sickness. Men and the Culture of Caregiving Launches as Podcast Sharing Powerful Stories of Male Caregivers [Yahoo! Finance]
2/28
07:48 am
fold
Amicus Therapeutics Inc (FOLD) Reports 21% Revenue Growth in 2023, Eyes Non-GAAP Profitability ... [Yahoo! Finance]
Medium
Report
Amicus Therapeutics Inc (FOLD) Reports 21% Revenue Growth in 2023, Eyes Non-GAAP Profitability ... [Yahoo! Finance]
2/28
07:10 am
fold
Amicus Therapeutics Announces Full-Year 2023 Financial Results and Corporate Updates [Yahoo! Finance]
Medium
Report
Amicus Therapeutics Announces Full-Year 2023 Financial Results and Corporate Updates [Yahoo! Finance]
2/28
07:00 am
fold
Amicus Therapeutics Announces Full-Year 2023 Financial Results and Corporate Updates
Medium
Report
Amicus Therapeutics Announces Full-Year 2023 Financial Results and Corporate Updates
2/15
07:00 am
fold
Amicus Therapeutics to Announce Full Year 2023 Financial Results on February 28, 2024
Medium
Report
Amicus Therapeutics to Announce Full Year 2023 Financial Results on February 28, 2024
2/14
04:58 pm
fold
Fabry Disease Treatment Market: Comprehensive Insights and Growth Projections for 2024-2030 [Yahoo! Finance]
Medium
Report
Fabry Disease Treatment Market: Comprehensive Insights and Growth Projections for 2024-2030 [Yahoo! Finance]
2/8
07:19 am
fold
Amicus Therapeutics Receives the 2024 New Treatment Award for Pombiliti™ (cipaglucosidase alfa-atga) + Opfolda™ (miglustat) at the 20th Annual WORLDSymposium™ [Yahoo! Finance]
Low
Report
Amicus Therapeutics Receives the 2024 New Treatment Award for Pombiliti™ (cipaglucosidase alfa-atga) + Opfolda™ (miglustat) at the 20th Annual WORLDSymposium™ [Yahoo! Finance]
2/8
07:00 am
fold
Amicus Therapeutics Receives the 2024 New Treatment Award for Pombiliti™ (cipaglucosidase alfa-atga) + Opfolda™ (miglustat) at the 20th Annual WORLDSymposium™
High
Report
Amicus Therapeutics Receives the 2024 New Treatment Award for Pombiliti™ (cipaglucosidase alfa-atga) + Opfolda™ (miglustat) at the 20th Annual WORLDSymposium™